A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

Induced Pluripotent Stem Cell Generation from Blood Cells Using Sendai Virus and Centrifugation

14.8K views

⸱

DOI:

10.3791/54650

⸱

December 21st, 2016

 ,  , 

In This Article

Summary

We propose a protocol for reprogramming peripheral blood mononuclear cells (PBMCs) into induced pluripotent stem cells (iPSCs). By plating the transduced blood cells onto matrix-coated plates with centrifugation, iPSCs are successfully induced from floating cells. This technique suggests a simple and effective reprogramming protocol for cells such as PBMCs and CBMCs.

Abstract

The recent development of human induced pluripotent stem cells (hiPSCs) proved that mature somatic cells can return to an undifferentiated, pluripotent state. Now, reprogramming is done with various types of adult somatic cells: keratinocytes, urine cells, fibroblasts, etc. Early experiments were usually done with dermal fibroblasts. However, this required an invasive surgical procedure to obtain fibroblasts from the patients. Therefore, suspension cells, such as blood and urine cells, were considered ideal for reprogramming because of the convenience of obtaining the primary cells. Here, we report an efficient protocol for iPSC generation from peripheral blood mononuclear cells (PBMCs). By plating the transduced PBMCs serially to a new, matrix-coated plate using centrifugation, this protocol can easily provide iPSC colonies. This method is also applicable to umbilical cord blood mononuclear cells (CBMCs). This study presents a simple and efficient protocol for the reprogramming of PBMCs and CBMCs.

Introduction

Stem cells have been one of the most attractive materials in clinical therapy for the last several decades1. The attractive properties of stem cells are pluripotency and the ability to self-renew. In 1981, the first embryonic stem cells (ESCs) were isolated from the mouse embryo2. However, when the technique was applied to human embryos, it faced several ethical issues.

In 2006, when Dr. Yamanaka and his team reprogrammed the first pluripotent cell from mouse somatic cells, the stem cell field regained its possibility and interest was rekindled3. By delivering several defined factors, pluripotent stem cells ....

Access restricted. Please log in or start a trial to view this content.

Protocol

Ethics Statement: This study protocol was approved by the institutional review board of The Catholic University of Korea (KC12TISI0861).

1. Isolation of Monocytic Cells from Blood

  1. Isolation of monocytic cells (Day -5)
    1. Obtain at least 10 ml of fresh blood from a blood draw in a cell preparation tube (CPT).
    2. Transfer the blood to a new 50-ml conical tube and dilute it with sterile phosphate-buffered saline (PBS) at a 1:4 ratio.
      ​NOTE: A higher ratio of dilution can be used for higher purity.
    3. Add 10 ml of density gradient media to a new 50-ml conical tube and carefully layer the diluted blood on top of the....

Access restricted. Please log in or start a trial to view this content.

Results

This protocol presents a simple method to reprogram PBMCs isolated from blood. Using the combination of serial plating and centrifugation, iPSCs were successfully generated. With this method, iPSCs could be generated with a small amount of whole blood cells without isolating or expanding a specific cell type. We successfully generated iPSCs from only 1x104 cells in a small cell culture plate.

Before reprogramming, blo.......

Access restricted. Please log in or start a trial to view this content.

Discussion

Since embryonic stem cells (ESCs) showed several shortcomings, the need of an alternative tool was required. Therefore, the development of induced pluripotent stem cells (iPSCs) by Yamanaka came under the international spotlight. It has been almost a decade since Yamanaka discovered that pluripotency can be induced by adding only four genes into adult somatic cells. Since iPSCs are "induced" from mature somatic cells, they can evade ethical issues that had once been the concern relating to ESCs. Unlike ESCs, iPSC.......

Access restricted. Please log in or start a trial to view this content.

Disclosures

The authors have nothing to disclose.

Acknowledgements

This work was supported by a grant from the Basic Science Research Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Science, ICT, and Future Planning (2013R1A1A1076125).

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
Plasticware
100 mm DishTPP 93100
6-well PlateTPP92006
50 ml Cornical TubeSPL50050
15 ml Cornical TubeSPL50015
10 ml Disposable PipetteFalcon7551
5 ml Disposable PipetteFalcon7543
12-well PlateTPP92012
24-well PlateTPP92024
PBMC Isolation Materials
DPBSLife Technologies14190-144
FicollGE Healthcare17-1440-03
StemSpanSTEMCELL Technologies9805Blood cell media
CC110STEMCELL Technologies8697Blood cell media supplement (100x)
iPSC Generation and Culture Materials
CytoTune-iPSC Sendai Reprogramming KitLife TechnologiesA16518
TeSR-E8 MediaSTEMCELL Technologies5940iPSC media
VitronectinLife TechnologiesA14700
ROCK InhibitorSigma AldrichY0503
TrypLE express (TrypLE)Life Technologies12604-039
ReleSRSTEMCELL Technologies12604-039Colony detaching solution
Quality Control Materials
18 mm Cover GlassSuperiorHSU-0111580
4% ParaformaldyhydeTech & InnovationBPP-9004
Triton X-100BIOSESANG9002-93-1
Bovine Serum Albumin Vector LabSP-5050 
Anti-SSEA4 AntibodyMilliporeMAB4304
Anti-Oct4 AntibodySanta CruzSC9081
Anti-TRA-1-60 AntibodyMilliporeMAB4360
Anti-Sox2 AntibodyBiolegend630801
Anti-TRA-1-81 AntibodyMilliporeMAB4381
Anti-Klf4 AntibodyAbcamab151733
Alexa Fluor 488 goat anti-mouse IgG (H+L) antibodyMolecular ProbeA11029
Alexa Fluor 594 goat anti-rabbit IgG (H+L) antibodyMolecular ProbeA11037
DAPIMolecular ProbeD1306
Prolong gold antifade reagentInvitrogenP36934
Slide Glass, Coated Hyun Il Lab-MateHMA-S9914
TrizolInvitrogen15596-018
ChloroformSigma Aldrich366919
IsoprypylalcoholMillipore109634
EthanolDuksan64-17-5
RevertAid First Strand cDNA Synthesis kitThermo ScientficK1622
i-Taq DNA PolymeraseiNtRON BIOTECH25021
UltraPure 10X TBE Buffer Life Technologies15581-044
loading starDyne BioA750
AgaroseSigma-Aldrich9012-36-6
1kb (+) DNA ladder markerEnzynomicsDM003
Alkaline PhosphataseMilliporeSCR004
Tris baseFisher ScientificBP152-1Rinse Buffer
Sodium ChlorideDuchefa BiochemieS0520.1000Rinse Buffer
Tween-20BIOSESANGT1027Rinse Buffer
Hydrochloric AcidDuksan1129Rinse Buffer

References

  1. Serra, M., Brito, C., Correia, C., Alves, P. M. Process engineering of human pluripotent stem cells for clinical application. Trends Biotechnol. 30 (6), 350-359 (2012).
  2. Martin, G. R. Isolation of a plur....

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Explore More Articles

Induced Pluripotent Stem CellsPeripheral Blood Mononuclear CellsSendai Virus ReprogrammingCentrifugation ProtocolVitronectin CoatingStromal Vascular FractionAlkaline Phosphatase StainingPluripotent Marker ExpressionColony Picking ProcedureSerial Plating Method